<h4>Introduction</h4>Positron emission tomography (PET) imaging with ligands for synaptic vesicle glycoprotein 2A (SV2A) has emerged as a promising methodology for measuring synaptic density in Alzheimer's disease (AD). Here, SV2A is linked to Alzheimer disease.